Eos, MITF, and PU.1 Recruit Corepressors to Osteoclast-Specific Genes in Committed Myeloid Progenitors
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Transcription factors MITF and PU.1 collaborate to increase expression of target genes like cathepsin K (Ctsk) and acid phosphatase 5 (Acp5) during osteoclast differentiation. We show that these factors can also repress transcription of target genes in committed myeloid precursors capable of forming either macrophages or osteoclasts. The direct interaction of MITF and PU.1 with the zinc finger protein Eos, an Ikaros family member, was necessary for repression of Ctsk and Acp5. Eos formed a complex with MITF and PU.1 at target gene promoters and suppressed transcription through recruitment of corepressors CtBP (C-terminal binding protein) and Sin3A, but during osteoclast differentiation, Eos association with Ctsk and Acp5 promoters was significantly decreased. Subsequently, MITF and PU.1 recruited coactivators to these target genes, resulting in robust expression of target genes. Overexpression of Eos in bone marrow-derived precursors disrupted osteoclast differentiation and selectively repressed transcription of MITF/PU.1 targets, while small interfering RNA knockdown of Eos resulted in increased basal expression of Ctsk and Acp5. This work provides a mechanism to account for the modulation of MITF and PU.1 activity in committed myeloid progenitors prior to the initiation of osteoclast differentiation in response to the appropriate extracellular signals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PU.1 has been shown to act in concert with MITF to recruit co-repressors to osteoclast-specific in committed myeloid precursors capable of forming either macrophages or OC [50].”
From PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation (2013) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · cited 3×
“It is now well established that many human bone disorders, including osteoporosis, Paget’s disease, and rheumatoid arthritis result from the imbalance in the differentiation and function of these two cell types (1).”
BackgroundRequirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · cited 3×
“Further, the N-terminal region of MITF (1-218) (MITF with aa 1 to 218), but not the C-terminal basic helix-loop-helixleucine zipper region (aa 219 to 419), formed a complex with GST-Eos (Fig.”
BackgroundThe ikaros gene is required for the development of all lymphoid lineages
Georgopoulos, K., Bigby, M., Wang, J.-H., Molnar, A., Wu, P., Winandy, S., & Sharpe, A. (1994) · Cell · doi:10.1016/0092-8674(94)90407-3 · Cited by 985 · cited 3×
“Further, the N-terminal region of MITF (1-218) (MITF with aa 1 to 218), but not the C-terminal basic helix-loop-helixleucine zipper region (aa 219 to 419), formed a complex with GST-Eos (Fig.”
BackgroundRb Interacts with Histone Deacetylase to Repress Transcription
Luo, R. X., Postigo, A. A., & Dean, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)80940-x · Cited by 960 · cited 2×
“Further, the N-terminal region of MITF (1-218) (MITF with aa 1 to 218), but not the C-terminal basic helix-loop-helixleucine zipper region (aa 219 to 419), formed a complex with GST-Eos (Fig.”
BackgroundMcGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y.-L., Ramaswamy, S., Avery, W., Ding, H.-F., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00762-6 · Cited by 760 · cited 2×
“Further, the N-terminal region of MITF (1-218) (MITF with aa 1 to 218), but not the C-terminal basic helix-loop-helixleucine zipper region (aa 219 to 419), formed a complex with GST-Eos (Fig.”
BackgroundMultilineage Transcriptional Priming and Determination of Alternate Hematopoietic Cell Fates
Laslo, P., Spooner, C. J., Warmflash, A., Lancki, D. W., Lee, H.-J., Sciammas, R., Gantner, B. N., Dinner, A. R., & Singh, H. (2006) · Cell · doi:10.1016/j.cell.2006.06.052 · Cited by 632
Wang, J.-H., Nichogiannopoulou, A., Wu, L., Sun, L., Sharpe, A. H., Bigby, M., & Georgopoulos, K. (1996) · Immunity · doi:10.1016/s1074-7613(00)80269-1 · Cited by 617 · cited 3×
“Further, the N-terminal region of MITF (1-218) (MITF with aa 1 to 218), but not the C-terminal basic helix-loop-helixleucine zipper region (aa 219 to 419), formed a complex with GST-Eos (Fig.”
BackgroundIkaros DNA-Binding Proteins Direct Formation of Chromatin Remodeling Complexes in Lymphocytes
Kim, J., Sif, S., Jones, B., Jackson, A., Koipally, J., Heller, E., Winandy, S., Viel, A., Sawyer, A., Ikeda, T., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80034-5 · Cited by 587 · cited 3×
“Further, the N-terminal region of MITF (1-218) (MITF with aa 1 to 218), but not the C-terminal basic helix-loop-helixleucine zipper region (aa 219 to 419), formed a complex with GST-Eos (Fig.”
BackgroundCell biology of the osteoclast
Roodman, G. D. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00061-2 · Cited by 571 · cited 3×
“Further, the N-terminal region of MITF (1-218) (MITF with aa 1 to 218), but not the C-terminal basic helix-loop-helixleucine zipper region (aa 219 to 419), formed a complex with GST-Eos (Fig.”
BackgroundSteingrímsson, E., Moore, K. J., Lamoreux, M. L., Ferré-D'Amaré, A. R., Burley, S. K., Sanders Zimring, D. C., Skow, L. C., Hodgkinson, C. A., Arnheiter, H., Copeland, N. G., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-256 · Cited by 493 · cited 3×
“Further, the N-terminal region of MITF (1-218) (MITF with aa 1 to 218), but not the C-terminal basic helix-loop-helixleucine zipper region (aa 219 to 419), formed a complex with GST-Eos (Fig.”
Background
Cited by
Cellular and molecular mechanisms of bone remodeling
Raggatt, L. J., & Partridge, N. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.041087 · Cited by 1,402
Pten in stromal fibroblasts suppresses mammary epithelial tumours
Trimboli, A. J., Cantemir-Stone, C. Z., Li, F., Wallace, J. A., Merchant, A., Creasap, N., Thompson, J. C., Caserta, E., Wang, H., Chong, J.-L., et al. (2009) · Nature · doi:10.1038/nature08486 · Cited by 500
Self-citationEos Mediates Foxp3-Dependent Gene Silencing in CD4 + Regulatory T Cells
Pan, F., Yu, H., Dang, E. V., Barbi, J., Pan, X., Grosso, J. F., Jinasena, D., Sharma, S. M., McCadden, E. M., Getnet, D., et al. (2009) · Science · doi:10.1126/science.1176077 · Cited by 334
Self-citationThe master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology
Kawakami, A., & Fisher, D. E. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.9 · Cited by 326
The role of cytokines in inflammatory bone loss
Souza, P. P. C., & Lerner, U. H. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.822766 · Cited by 269
“Stimulation of osteoclastogenesis is associated with decreased expression of Eos, but also phosphorylation of MITF and subsequent recruitment of coactivators are mechanisms to overcome the inhibitory effect of Eos (Hu et al., 2007).”
BackgroundInfluentialThe Ikaros gene family: Transcriptional regulators of hematopoiesis and immunity
John, L. B., & Ward, A. C. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.03.006 · Cited by 231
de la Rica, L., Rodríguez-Ubreva, J., García, M., Islam, A. B., Urquiza, J. M., Hernando, H., Christensen, J., Helin, K., Gómez-Vaquero, C., & Ballestar, E. (2013) · Genome Biology · doi:10.1186/gb-2013-14-9-r99 · Cited by 211
“1 has been shown to act in concert with MITF to recruit co-repressors to osteoclast-specific in committed myeloid precursors capable of forming either macrophages or OC [50].”
Impaired Micro-RNA Pathways Diminish Osteoclast Differentiation and Function
Sugatani, T., & Hruska, K. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805777200 · Cited by 196
Molecular mechanisms and clinical management of cancer bone metastasis
Wang, M., Xia, F., Wei, Y., & Wei, X. (2020) · Bone Research · doi:10.1038/s41413-020-00105-1 · Cited by 193
“The recruitment of TNF receptor-associated factors (TRAFs) is crucial for RANK/RANKL-mediated osteoclastogenesis, which activates various transcription factors, such as nuclear factor kappa beta and AP-1, and prevents the apoptosis of mature osteoclasts.83,84 RANKL also induces the phosphorylation of another transcrip…”
BackgroundEts1 and ets2 are required for endothelial cell survival during embryonic angiogenesis
Wei, G., Srinivasan, R., Cantemir-Stone, C. Z., Sharma, S. M., Santhanam, R., Weinstein, M., Muthusamy, N., Man, A. K., Oshima, R. G., Leone, G., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211391 · Cited by 185
Self-citationZhao, B., Grimes, S. N., Li, S., Hu, X., & Ivashkiv, L. B. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111566 · Cited by 182
“322 RBP-J regulates osteoclastogenesis and bone resorption | Zhao et al. for other repressors of osteoclastogenesis (Lee et al., 2006; Hu et al., 2007; Kim et al., 2007; Zhao et al., 2009; Miyauchi et al., 2010; Zhao and Ivashkiv, 2011) and functions to release osteoclast precursors from inhibitors…”
BackgroundInfluentialZhao, B., & Ivashkiv, L. B. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3379 · Cited by 144
Acharyya, S., Sharma, S. M., Cheng, A. S., Ladner, K. J., He, W., Kline, W., Wang, H., Ostrowski, M. C., Huang, T. H., & Guttridge, D. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012479 · Cited by 136
“ChIP analysis Chromatin immunoprecipitation were performed as described [62].”
MethodSelf-citationAn Ets2 -Driven Transcriptional Program in Tumor-Associated Macrophages Promotes Tumor Metastasis
Zabuawala, T., Taffany, D. A., Sharma, S. M., Merchant, A., Adair, B., Srinivasan, R., Rosol, T. J., Fernandez, S., Huang, K., Leone, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1474 · Cited by 117
Self-citationMellis, D. J., Itzstein, C., Helfrich, M. H., & Crockett, J. C. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0212 · Cited by 112
“1 to become active and up-regulate osteoclastogenesis (Hu et al. 2007).”
BackgroundJanckila, A. J., & Yam, L. T. (2009) · Calcified Tissue International · doi:10.1007/s00223-009-9309-8 · Cited by 116
“One of the more extensively studied systems for regulating Acp5 is that involving MiTF and its interactions with other factors [104–108].”
BackgroundMicrophthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB
Ripoll, V. M., Meadows, N. A., Raggatt, L. J., Chang, M. K., Pettit, A. R., Cassady, A. I., & Hume, D. A. (2008) · Gene · doi:10.1016/j.gene.2008.01.014 · Cited by 108
HDAC3 and HDAC7 Have Opposite Effects on Osteoclast Differentiation
Pham, L., Kaiser, B., Romsa, A., Schwarz, T., Gopalakrishnan, R., Jensen, E. D., & Mansky, K. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.216853 · Cited by 88
Mazzurana, L., Forkel, M., Rao, A., Acker, A. V., Kokkinou, E., Ichiya, T., Almer, S. H., Höög, C., Friberg, D., & Mjösberg, J. (2019) · European Journal of Immunology · doi:10.1002/eji.201848075 · Cited by 94
MITF reprograms the extracellular matrix and focal adhesion in melanoma
Dilshat, R., Fock, V., Kenny, C., Gerritsen, I., Lasseur, R. M. J., Travnickova, J., Eichhoff, O. M., Cerny, P., Möller, K., Sigurbjörnsdóttir, S., et al. (2021) · eLife · doi:10.7554/elife.63093 · Cited by 84
PU.1 and NFATc1 mediate osteoclastic induction of the mouse β3 integrin promoter
Crotti, T. N., Sharma, S. M., Fleming, J. D., Flannery, M. R., Ostrowski, M. C., Goldring, S. R., & McHugh, K. P. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21344 · Cited by 76
“ChIP assays were performed as described (Hu et al., 2007; Sharma et al., 2007).”
Self-citationZhu, S., Yan, M.-Q., Masson, A., Chen, W. "., & Li, Y. (2026) · Cell Discovery · doi:10.1038/s41421-025-00853-6 · Cited by 79
“ChIP analyses further demonstrate that upon M-CSF stimulation, MITF and PU.1 are recruited to the Ctsk and Acp5 promoters together with co-repressors including CTBP, Sin3A, and HDAC1 206,207 .”
InfluentialBone Remodeling: Histone Modifications as Fate Determinants of Bone Cell Differentiation
Yi, S.-J., Lee, H.-R., Lee, J., Lee, K., Kim, J., Kim, Y., Park, J., & Kim, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133147 · Cited by 75
Balkan, W., Martinez, A. F., Fernández, I. C., Rodriguez, M. A., Pang, M., & Troen, B. R. (2009) · Gene · doi:10.1016/j.gene.2009.06.013 · Cited by 69
CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth
Mathsyaraja, H., Thies, K., Taffany, D. A., Deighan, C., Liu, T., Yu, L., Fernandez, S. A., Shapiro, C., Otero, J., Timmers, C., et al. (2015) · Oncogene · doi:10.1038/onc.2014.294 · Cited by 65
Self-citationYazid, M. D., Ariffin, S. H. Z., Senafi, S., Razak, M. A., & Wahab, R. M. A. (2010) · Cancer Cell International · doi:10.1186/1475-2867-10-42 · Cited by 64
The Ikaros family of zinc-finger proteins
Fan, Y., & Lu, D. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.06.002 · Cited by 61
Courtial, N., Smink, J. J., Kuvardina, O. N., Leutz, A., Göthert, J. R., & Lausen, J. (2011) · The FASEB Journal · doi:10.1096/fj.11-190850 · Cited by 55
“finger transcription factor EOS, Sin3a, and HDAC1 on the Acp5 and CTSK promoters in committed myeloid progenitors (56).”
BackgroundBiology of melanocytes in mammals
Cui, Y.-Z., & Man, X. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1309557 · Cited by 53
Vaňhara, P., Slabáková, E., Kozubík, A., Jurdic, P., Souček, K., & Šmarda, J. (2009) · Differentiation · doi:10.1016/j.diff.2009.07.008 · Cited by 47
“7 cells using both types of conditioned media were stained for TRAP and enumerated by light microscopy.”
InfluentialThe “soft” side of the bone: unveiling its endocrine functions
Cappariello, A., Ponzetti, M., & Rucci, N. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0009 · Cited by 44
EZH2 Supports Osteoclast Differentiation and Bone Resorption Via Epigenetic and Cytoplasmic Targets
Adamik, J., Pulugulla, S. H., Zhang, P., Sun, Q., Lontos, K., Macar, D. A., Auron, P. E., & Galson, D. L. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3863 · Cited by 44
Remen, K. M. R., Henning, P., Lerner, U. H., Gustafsson, J.-Α., & Andersson, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.235937 · Cited by 45
PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells
Yashiro, T., Kubo, M., Ogawa, H., Okumura, K., & Nishiyama, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137699 · Cited by 45
“1 represses transcription of osteoclast marker genes, such as cathepsin K and acid phosphatase 5 [13].”
BackgroundRegulation of Osteoclast Differentiation and Skeletal Maintenance by Histone Deacetylases
Faulkner, B., Astleford, K., & Mansky, K. C. (2019) · Molecules · doi:10.3390/molecules24071355 · Cited by 43
“There are 18 HDACs within the human genome, each of which are distributed into four different classes: class I HDACs (HDACs 1–3,8), class II HDACs (HDACs 4–7,9,10), class III HDACs (Sirtuins 1–7), and class IV HDAC, HDAC11, [9].”
BackgroundInfluentialKamath, M. B., Houston, I. B., Janovski, A. J., Zhu, X., Gowrisankar, S., Jegga, A. G., & DeKoter, R. P. (2008) · Leukemia · doi:10.1038/leu.2008.67 · Cited by 41
Carey, H. A., Hildreth, B. E., Geisler, J. A., Nickel, M. C., Cabrera, J., Ghosh, S., Jiang, Y., Yan, J., Lee, J., Makam, S., et al. (2018) · Bone Research · doi:10.1038/s41413-018-0011-1 · Cited by 40
“1 target promoters.(20,51) Though MITF and PU.”
Self-citationIntrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption
Zhao, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.583561 · Cited by 43
Lipopolysaccharide suppresses RANK gene expression in macrophages by down‐regulating PU.1 and MITF
Ishii, J., Kitazawa, R., Mori, K., McHugh, K. P., Morii, E., Kondo, T., & Kitazawa, S. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21886 · Cited by 40
“As a cue to resolving this question, recently identified corepressor Eos [Hu et al., 2007], a zinc finger protein capable of forming a complex with MITF and PU.1, may partly be involved in suppressing RANK gene in committed myeloid 902 RANK GENE SUPPRESSION BY LPS progenitors.”
Backgroundp38 MAPK‐dependent phosphorylation of TFEB promotes monocyte‐to‐macrophage differentiation
Martina, J. A., Jeong, E., & Puertollano, R. (2022) · EMBO Reports · doi:10.15252/embr.202255472 · Cited by 34
“This phosphorylation allows the recruitment of transcriptional co-activators FUS and BRG1, leading to the expression of the MITF targets TRAP, OSCAR, CLCN7, and cathepsin K, which are necessary for osteoclasts function (Sharma et al , 2007; Bronisz et al , 2014).”
Mast cell transcriptional networks
Takemoto, C. M., Lee, Y.-N., Jegga, A. G., Zablocki, D., Brandal, S., Shahlaee, A. H., Huang, S., Ye, Y., Gowrisankar, S., Huynh, J. L., et al. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2008.02.005 · Cited by 34
Stemig, M., Astleford, K., Emery, A., Cho, J. J., Allen, B., Huang, T., Gopalakrishnan, R., Mansky, K. C., & Jensen, E. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123843 · Cited by 35
“In early osteoclast progenitors stimulated with M-CSF only, MITF and PU.1 are recruited to and repress osteoclast gene promoters including Ctsk and Acp5[5,20].”
BackgroundInfluentialOppezzo, A., & Rosselli, F. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00529-0 · Cited by 32
“The Ikaros family protein Eos interacts with both MiTF and PU.1 to repress transcription at specific promoters through the recruitment of the corepressors Sin3A and CtBP [51].”
BackgroundBronisz, A., Carey, H. A., Godlewski, J. A., Sif, S., Ostrowski, M. C., & Sharma, S. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.493874 · Cited by 34
“Because SUMO modification is known to increase the affinity of corepressor complexes for transcription factors (35), an alternative SUMO protease involved in SUMO precursor processing (34) may be present in the MITF-EOS corepressor complex that prevents activation of target genes in osteoclast precursors (10).”
BackgroundInfluentialSelf-citationBian, Z., Luo, Y., Guo, F., Huang, Y., Zhong, M., & Cao, H. (2019) · Europe PMC (PubMed Central) · Cited by 29
Proteomic Analysis of Estrogen-Mediated Signal Transduction in Osteoclasts Formation
Xiong, Q., Tang, P., Gao, Y., Zhang, L., & Ge, W. (2015) · BioMed Research International · doi:10.1155/2015/596789 · Cited by 31
“TRAP staining confirmed that RANKL efficiently induced the formation of mature osteoclasts on day 5.”
BackgroundInfluentialHume, D. A., Sasmono, R. T., Himes, S. R., Sharma, S. M., Bronisz, A., Constantin, M., Ostrowski, M. C., & Ross, I. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6733 · Cited by 29
Self-citationCarey, H. A., Hildreth, B. E., Samuvel, D. J., Thies, K., Rosol, T. J., Toribio, R. E., Charles, J. F., Ostrowski, M. C., & Sharma, S. M. (2018) · iScience · doi:10.1016/j.isci.2018.12.018 · Cited by 26
“Previously, we have shown by ReChIP analysis that PU.1 and MITF can simultaneously occupy specific regions of chromatin (Hu et al., 2007).”
BackgroundSelf-citationMultifunctional Properties of RANKL/RANK in Cell Differentiation, Proliferation and Metastasis
Kukita, A., & Kukita, T. (2013) · Future Oncology · doi:10.2217/fon.13.115 · Cited by 25
“Activation of NF-kB and c-Fos leads to the induction of NFATc1, which stimulates the expression of osteoclast-specific genes such as cathepsin K. RANKL also induces the phosphorylation of MITF, which is another transcription factor involved in osteoclastogenesis that is activated downstream of MAPK [24].”
InfluentialSirt6 cooperates with Blimp1 to positively regulate osteoclast differentiation
Park, S. J., Huh, J.-E., Shin, J., Park, D. R., Ko, R., Jin, G.-R., Seo, D.-H., Kim, H. S., Shin, H.-I., Oh, G. T., et al. (2016) · Scientific Reports · doi:10.1038/srep26186 · Cited by 23
Role of histone deacetylases in bone development and skeletal disorders
Wang, J. S., Yoon, S.-H., & Wein, M. N. (2020) · Bone · doi:10.1016/j.bone.2020.115606 · Cited by 23
“The reported function of Hdac1 is to serve as a transcriptional corepressor by localizing the promoters of osteoclast genes, such as Nfatc1, Oscar, Ctsk and Acp5 [68].”
BackgroundLi, X.-H., Kishore, A. H., Dao, D., Zheng, W., Roman, C. A. J., & Word, R. A. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0320 · Cited by 26
“This is consistent with the known repressive properties of MiTF in B cells and macrophages (47, 48) in which MiTF blocks programs of activation by repressing gene expression.”
ResultRamón-Vázquez, A., Flood, P. F., Cashman, T. L., Patil, P., & Ghosh, S. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103735 · Cited by 20
PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells
Bheda, A., Yue, W., Gullapalli, A., Shackelford, J., & Pagano, J. S. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.562571 · Cited by 19
Andersson, L. S., Lyberg, K., Cothran, E. G., Ramsey, D. T., Juras, R., Mikko, S., Ekesten, B., Ewart, S., & Lindgren, G. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9325-7 · Cited by 19
Pin1, the Master Orchestrator of Bone Cell Differentiation
Islam, R., Yoon, W., & Ryoo, H. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25442 · Cited by 17
“1 at its target promoters has been shown to allow committed precursors the flexibility to respond rapidly to the bone microenvironment and reprogram gene expression in response to RANKL signaling (Hu et al., 2007).”
BackgroundFHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy
Rachmin, I., Amsalem, E., Golomb, E., Beeri, R., Gilon, D., Fang, P., Nechushtan, H., Kay, G., Guo, M., Yiqing, P. L., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.108 · Cited by 18
Inhibition of osteoclast differentiation by overexpression of NDRG2 in monocytes
Kang, K., Nam, S., Kim, B., Lim, J. H., Yang, Y. D., Lee, M.-S., & Lim, J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.167 · Cited by 15
The Large Zinc Finger Protein ZAS3 Is a Critical Modulator of Osteoclastogenesis
Liu, S., Madiai, F., Hackshaw, K. V., Allen, C. E., Carl, J. W., Huschart, E., Karanfilov, C. I., Litsky, A. S., Hickey, C. J., Marcucci, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017161 · Cited by 12
“1 and EOS, has been characterized [23].”
Blinova, V. G., Novachly, N. S., Gippius, S. N., Hilal, A., Gladilina, Y. A., Eliseeva, D. D., & Zhdanov, D. D. (2021) · Applied Sciences · doi:10.3390/app11135776 · Cited by 12
The Role of Jak/STAT Pathways in Osteoclast Differentiation
Lee, Y., & Kim, H. H. (2011) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2011.19.2.141 · Cited by 12
“For example, protease cathepsin K, produced upon MITF transactivation (Hu et al., 2007), catabolizes collagen matrices to degrade bone and cartilage.”
BackgroundDefective co‐activator recruitment in osteoclasts from microphthalmia‐oak ridge mutant mice
Sharma, S. M., Sif, S., Ostrowski, M. C., & Sankar, U. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21755 · Cited by 11
“L I S S , I N C . of Acp5 and Ctsk during osteoclast differentiation (Luchin et al., 2001; Hu et al., 2007).”
BackgroundMethodSelf-citationXiong, Q., Zhang, L., Zhan, S., Ge, W., & Tang, P. (2016) · Proteome Science · doi:10.1186/s12953-016-0097-6 · Cited by 10
Opposite effects of PU.1 on mast cell stimulation
Niwa, Y., Nishiyama, C., Nakano, N., Kamei, A., Kato, H., Kanada, S., Ikeda, S., Ogawa, H., & Okumura, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.129 · Cited by 10
Eos Negatively Regulates Human γ-globin Gene Transcription during Erythroid Differentiation
Yu, H., Zhao, H.-L., Wu, Z., & Zhang, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022907 · Cited by 11
“1, or microphthalmiaassociated transcription factor (MITF) to repress transcription of cathepsin K and tartrate-resistant acid phosphatase (TRAP) promoters [21,24].”
BackgroundMethodCarey, H. A., Bronisz, A., Cabrera, J. S., Hildreth, B. E., Cuitiño, M. C., Fu, Q., Ahmad, A., Toribio, R. E., Ostrowski, M. C., & Sharma, S. M. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25108 · Cited by 11
“EOS recruits co-repressors including HDAC, Sin3A, and CtBP to these sites (Hu et al., 2007).”
BackgroundSelf-citationN16 suppresses RANKL-mediated osteoclatogenesis by down-regulating RANK expression
Lin, J.-B., Wu, H., Liu, Y., Shaw, P., & Li, P. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.10.159 · Cited by 7
Karlström, E., Ek‐Rylander, B., Wendel, M., & Andersson, G. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2010.12.010 · Cited by 7
“1, and AP-1, several osteoclast-specific genes, among them TRAP, OSCAR, calcitonin receptor, and cathepsin K [7,37], although the components of the transcriptional complex are not always the same [38,39].”
BackgroundKitazawa, R., Kinto-Shibahara, S., Haraguchi, R., Kohara, Y., & Kitazawa, S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.144 · Cited by 6
Regulation of human ZNF687, a gene associated with Paget's disease of bone
Varela, D., Varela, T., Conceição, N., & Cancela, M. L. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106332 · Cited by 6
Chugh, R. M., Bhanja, P., Olea, X. D., Fang, T., Schroeder, K., Zitter, R., Arora, T., Pathak, H. B., Kimler, B. F., Godwin, A. K., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105498 · Cited by 5
Genetic and Epigenetic Aspects of Bone Development
O’Connor, R. D., Farach‐Carson, M. C., & Schanen, N. C. (2010) · Springer eBooks · doi:10.1007/978-1-84882-822-3_1 · Cited by 8
“1 that specifically regulates the target genes during osteoclastic differentiation [69, 153].”
BackgroundThe T-Cell Oncogene Tal2 Is a Target of PU.1 and Upregulated during Osteoclastogenesis
Courtial, N., Mücke, C., Herkt, S. C., Kolodziej, S., Hussong, H., & Lausen, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076637 · Cited by 5
Basic Aspects of Osteoclast Differentiation and Function
Alesi, N., Charles, J. F., & Nakamura, M. C. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_2 · Cited by 6
Redundant function of Ets1 and Ets2 in regulating M-phase progression in post-natal angiogenesisPreprint
Ghosh, S., MarElia, C. B., Hildreth, B. E., Lefler, J. E., Sharma, S. M., & Ostrowski, M. C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.19.956417 · Cited by 4
“Chromatin immunoprecipitation assays Chromatin immunoprecipitation (ChIP) assays were performed on cultured aortic ECs as described previously (36).”
MethodSelf-citationEngineering of Inflammation-Resistant Osteochondral Cells
O, J., Janne, E., Tommy, A., Jakobsen, R. B., Astrid, K., Syversen, U., Engebretsen, L., Lyngstadaas, S. P., & Jorgense, C. (2013) · InTech eBooks · doi:10.5772/55544 · Cited by 2
Regulation of Bone Resorption by PPARγ
Wei, W., & Wan, Y. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-415784-2.00010-5 · Cited by 4
Origin and Differentiation of Osteoclasts
Sanjay, A., & Charles, J. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11161-4 · Cited by 1
Biogenesis of tartrate-resistant acid phosphatase isoforms 5a and 5b in cell and animal models
Zenger, S. (2010) · Figshare
Reduced HDAC7 expression results in increased osteoclastogenesis.
Allen, B. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
der Steen, T. V. (2012) · NDSU Repository (North Dakota State University)
Rôle des facteurs de transcription Eos et Helios dans la biologie des cellules T régulatrices
Polak, K. (2015) · theses.fr (ABES) · doi:10.70675/a05cabbezdb21z40e5zb964zce0e8c751cf4
RANKL Signaling Pathway: A Potential Target for Antiresorptive Therapy in Rheumatoid Arthritis
Anjum, S., Bhatti, A., Qadir, F., Ashraf, U., & John, P. C. L. (2021) · NUST Journal of Natural Sciences · doi:10.53992/njns.v3i1.20
Characterization of the human IDH1 gene promoter
Takihara, Y., Otani, R., Ishii, T., Takaoka, S., Nakano, Y., Inoue, K., Larsen, S. H., Ogino, Y., Asai, M., Tanuma, S., et al. (2023) · AIMS molecular science · doi:10.3934/molsci.2023013
Marchandet, L. (2022) · theses.fr (ABES) · doi:10.70675/0c2f40a9z2d28z449azb8c5zf92603e00c89
Melanocyte homeostasis regulation and skin disorders
Zheng, B., Zhu, Q., Wang, H., Li, C., & Guo, W. (2026) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0404
Apostolov, A. (2012) · theses.fr (ABES) · doi:10.70675/23bb8330zf47ez4a62z9f59z2301e60db09f · Cited by 1
Etude du rôle du facteur de transcription Helios dans les cellules souches hématopoïétiques
Vesin, R.-M. (2014) · theses.fr (ABES) · doi:10.70675/9f748940z1d7ez4a0cz935ez4a4adbd17642
Oppezzo, A. (2021) · theses.fr (ABES) · doi:10.70675/53736911zeb54z418czb336z493f788bd19f
Fan, S., Wang, R., Tang, K., Xie, L., Chen, Q., Sun, M., & Zhang, X. (2026) · Journal of Clinical Immunology · doi:10.1007/s10875-026-02055-5
(2008) · PubMed
Metadata
- Authors
- Hu, R., Sharma, S. M., Bronisz, A., Srinivasan, R., Sankar, U., & Ostrowski, M. C.
- Affiliations
- Duke University (US)
- Corresponding author
- Ostrowski, Michael C.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2007-06-01
- Volume
- 27
- Issue
- 11
- Pages
- 4018-4027
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC1900027
- OpenAlex
- W2155585495
- Cited by
- 86
- References
- 46
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 8 · 2018: 3 · 2017: 1 · 2016: 5 · 2015: 6 · 2014: 1 · 2013: 6 · 2012: 4
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR044719, R01 AR 0447129)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- EOS, MITF, PU.1, osteoclastogenesis, transcriptional repression, transcriptional activation, cathepsin K, CtBP, SIN3A, transcriptional coactivator, corepressors, macrophage differentiation, bone marrow
- MeSH terms
- Tartrate-Resistant Acid Phosphatase, Proto-Oncogene Protein Spi-1, Acid Phosphatase, Animals, Carrier Proteins, Cathepsins, Cell Differentiation, DNA-Binding Proteins, Humans, Isoenzymes, Nerve Tissue Proteins, Osteoclasts, Promoter Regions, Genetic, Proto-Oncogene Proteins, Repressor Proteins, Signal Transduction, Trans-Activators, Zinc Fingers, Gene Expression Regulation, Developmental, Myeloid Progenitor Cells, RNA, Small Interfering, NIH 3T3 Cells, Mice, Microphthalmia-Associated Transcription Factor, RANK Ligand, Cathepsin K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.